Gynecologic Oncology | Novel Agents and Emerging Strategies in the Management of Gynecologic Cancers

Faculty presentations from an independent satellite symposium during the Society of Gynecologic Oncology’s 2019 Annual Meeting on Women’s Cancer. Featuring perspectives from Dr Michael J Birrer, David M O’Malley, Matthew A Powell and Shannon N Westin: Biologic Rationale for and Current Research Database with Immune Checkpoint Inhibition in Gynecologic Cancers — Dr Powell (00:00) Targeting Folate Receptor Alpha (FRα) in Patients with Gynecologic Cancers — Dr Birrer (7:54) Other Novel Agents and Strategies Under Investigation for Cervical Cancer, Endometrial Cancer and Ovarian Cancer — Dr O’Malley (17:27) Ongoing Trials Examining the Role of Anti-PD-1/PD-L1 Antibodies in Combination with Chemotherapy, Targeted Agents or Other Immunotherapeutics — Dr Westin (27:50)  Select publications